help button home button Am J Pathol Epitomics Buy 2 Antibodies Get 1 Free Special Offer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nardacci, R.
Right arrow Articles by Piacentini, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nardacci, R.
Right arrow Articles by Piacentini, M.
(American Journal of Pathology. 2005;167:695-704.)
© 2005 American Society for Investigative Pathology

Characterization of Cell Death Pathways in Human Immunodeficiency Virus-Associated Encephalitis

Roberta Nardacci*, Andrea Antinori*, Luigi Maria Larocca{dagger}, Vincenzo Arena{dagger}, Alessandra Amendola*, Jean-Luc Perfettini{ddagger}, Guido Kroemer{ddagger} and Mauro Piacentini*§

From the National Institute for Infectious Diseases, Lazzaro Spallanzani,* Rome, Italy; the Institute of Pathological Anatomy,{dagger} Catholic University of Rome, School of Medicine, Rome, Italy; the Department of Biology,§ University of Rome "Tor Vergata," Rome, Italy; and CNRS-UMR8125,{ddagger} Institut Gustave Roussy, Villejuif, France

Human immunodeficiency virus (HIV)-associated dementia is a neurodegenerative syndrome characterized by cognitive decline, personality change, and motor deficits. HIV-associated encephalitis (HAE), the neuropathology responsible for HIV-associated dementia, involves the formation of multinucleated giant cells or syncytia. In this article we describe the apoptotic pathways activated in the brains of HAE-affected patients. Approximately 50% of multinuclear giant cells exhibited apoptotic DNA fragmentation as detected by the terminal dUTP nick-end labeling technique. In addition, the presence of syncytia in the frontal cortex of ~35% of HAE patients correlated with the number of cells expressing the HIV-1 protein p24. Histochemical and immunohistochemical analyses revealed that HAE-associated syncytia underwent apoptosis through a mitochondrial pathway previously delineated for HIV-1 envelope-elicited syncytia in vitro. We observed over-expression of the mammalian target of rapamycin (mTOR), a kinase that mediates activation of the pro-apoptotic transcription factor p53, and p53-dependent up-regulation of two effectors of mitochondrial apoptosis, namely the BH3-only proteins Puma and transglutaminase type 2 (TG2). Interestingly, although mTOR activation and Puma induction were observed in dying syncytia and neurons, IkB phosphorylation and TG2 up-regulation were only found in syncytia. These findings provide substantial new information on the cell death mechanisms that regulate HAE, suggesting an important pathogenetic role of syncytia in the disease.





This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
S T L Micchelli, D Thomas, J K Boitnott, and M Torbenson
Hepatic giant cells in hepatitis C virus (HCV) mono-infection and HCV/HIV co-infection
J. Clin. Pathol., September 1, 2008; 61(9): 1058 - 1061.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Society for Investigative Pathology.